Guselkumab treatment was associated with improvements in 3 biomarkers associated with systemic inflammation among patients with plaque psoriasis.

Anti-TFAM antibodies are detected in about one third of patients with systemic lupus erythematosus and are associated with a ...

Combined data from Studies CL-QRX003-002 and CL-QRX003-003 is anticipated to provide QRX003 with the broadest possible label ...

An AI-driven, 3D spatial multimodal analysis exposed substantial immune and structural dysregulation of the duodenum in ...

Merck KGaA said that cohort A met the primary endpoint in the Phase II lupus trial but cohort B failed to meet its primary ...

A new study identifies eight domains of active systemic #lupus erythematosus for defining meaningful treatment response in ...

Results from the Phase II WILLOW trial show that enpatoran achieved a statistically significant dose-response and clinically ...

Join Drs Maureen McMahon and Karen Costenbader as they explore how diet, pollution, infections, and lifestyle factors influence lupus risk and what patients can do about it.